0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Holly C. Gooding, MD, MSc; Angie Mae Rodday, MSc; John B. Wong, MD; et al.
JAMA Pediatr. 2015;169(6):569-574. doi:10.1001/jamapediatrics.2015.0168.

Research Letter | 
Terri Voepel-Lewis, PhD; Deborah Wagner, PharmD; Alan R. Tait, PhD
JAMA Pediatr. 2015;169(5):497-498. doi:10.1001/jamapediatrics.2014.3583.

Viewpoint | 
Rakesh D. Mistry, MD, MS; Peter S. Dayan, MD, MSc; Nathan Kuppermann, MD, MPH
JAMA Pediatr. 2015;169(5):421-422. doi:10.1001/jamapediatrics.2015.79.

Original Investigation |  ONLINE ONLY
David M. Rubin, MD, MSCE; Amanda R. Kreider, BS, BA; Meredith Matone, MHS; et al.
JAMA Pediatr. 2015;169(4):e150285. doi:10.1001/jamapediatrics.2015.0285.
Includes: Supplemental Content

Viewpoint | 
Geert W. ‘t Jong, MD, PhD; Terry P. Klassen, MD, MSc, FRCPC; Stuart M. MacLeod, BSc(Med), MD, PhD, FRCPC
JAMA Pediatr. 2015;169(3):204-205. doi:10.1001/jamapediatrics.2014.3057.

Viewpoint | 
Neil L. Schechter, MD
JAMA Pediatr. 2014;168(11):987-988. doi:10.1001/jamapediatrics.2014.1441.

Research Letter | 
Kathleen L. Dooling, MD, MPH; Daniel J. Shapiro, BA; Chris Van Beneden, MD, MPH; et al.
JAMA Pediatr. 2014;168(11):1073-1074. doi:10.1001/jamapediatrics.2014.1582.

Original Investigation | 
L. Charles Bailey, MD, PhD; Christopher B. Forrest, MD, PhD; Peixin Zhang, PhD; et al.
JAMA Pediatr. 2014;168(11):1063-1069. doi:10.1001/jamapediatrics.2014.1539.

Original Investigation |  FREE
Elizabeth V. Asztalos, MD; Kellie E. Murphy, MD; Andrew R. Willan, PhD; et al.
JAMA Pediatr. 2013;167(12):1102-1110. doi:10.1001/jamapediatrics.2013.2764.
Includes: Supplemental Content

Review | 
David Y. Hyun, MD; Adam L. Hersh, MD; Katie Namtu, PharmD; et al.
JAMA Pediatr. 2013;167(9):859-866. doi:10.1001/jamapediatrics.2013.2241.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Chemotherapy Near the End of Life First—and Third and Fourth (Line)—Do No Harm
Charles D. Blanke, MD; Erik K. Fromme, MD
JAMA Oncology
Original Investigation  | 
Chemotherapy Use, Performance Status, and Quality of Life at the End of Life
Holly G. Prigerson, PhD; Yuhua Bao, PhD; Manish A. Shah, MD; et al.
JAMA Psychiatry
Editorial  | 
Antipsychotic Use in Youth Without Psychosis A Double-edged Sword
Christoph U. Correll, MD; Joseph C. Blader, PhD
JAMA Psychiatry
Original Investigation  | 
Treatment of Young People With Antipsychotic Medications in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD